Cite
HARVARD Citation
Szlosarek, P. et al. (2021). Phase 1, pharmacogenomic, dose‐expansion study of pegargiminase plus pemetrexed and cisplatin in patients with ASS1‐deficient non‐squamous non‐small cell lung cancer. Cancer medicine. pp. 6642-6652. [Online].